HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

I started feeling even more exhausted than usual. I also had lower back and abdominal pain and bloating, but I shrugged it ...

Atrial Flutter Market Outlook 2025-2035 ... exhibiting a growth rate (CAGR) of 2.15% during 2024-2034. Myocardial Infarction Market: The 7 major myocardial infarction markets reached a value of US$ ...

This collection covers essential topics such as ECG interpretation, advanced cardiac life support (ACLS), and the latest heart attack and arrhythmia management protocols. Mastering cardiac care is ...

In June, Tempus gained 510(k) clearance from the FDA for Tempus ECG-AF, a device intended to help identify patients at an increased risk of atrial fibrillation or flutter. "Tempus launches AI ...

ACC's EP Device Implant Registry is a critical tool for tracking and improving outcomes for patients receiving ICD/CRT-D and pacemaker procedures. The newly launched Version 3.0 has streamlined ...

Garmin was relatively late to the party when it first received approval for its ECG app in 2023, but the feature has expanded considerably since then. Initially, only the Garmin Venu 2 Plus ...

Atrial fibrillation can impact your health and life span in a number of ways. A 2024 study followed the outcomes of 260,492 adults hospitalized for AFib or atrial flutter, a closely related cardiac ...

After many months, if not years, of leaks and speculation, it’s finally official: Nintendo has announced its next console, and it’s called Nintendo Switch 2. As the name implies, it’s a very ...

However, we can speculate that the Switch 2 won’t be released before June, given its hands-on event schedule runs up to June 1. Nintendo Switch 2 is larger than the Switch The video shows how ...